All sponsors

Biocad

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS21
PHASE 3 / 2-313
RECRUITING9
READOUTS ≤12 MONTHS4
READOUT SLIPPED >6 MO8%

Delay Index: of 12 active trials registered more than a year ago, 1 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Biocad on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
OCTAVA
NCT05732805
P3Active, not recruitingMelanoma; Melanoma (Skin)2702024-06-20
Levilimab
NCT05800327
P3Active, not recruitingRheumatoid Arthritis2612024-09
LIBERIUS
NCT05726630
P3Active, not recruitingSystemic Scleroderma1522024-10-01 (+2 mo)
anti-TRBV9 monoclonal antibody infusions
NCT06333210
P3Active, not recruitingAxial Spondyloarthritis4212024-12
AQUARELLE
NCT05730699
P3Active, not recruitingNeuromyelitis Optica Spectrum Disorders1052025-01
PREFER
NCT05802225
P3Active, not recruitingBreast Cancer3982025-06-06 (+16 mo)
BLUEBELL
NCT05747261
P1/2RecruitingSpinal Muscular Atrophy (SMA)402025-09
ANB-002, dose 1
NCT06120582
P1/2RecruitingHemophilia B282025-11
AREAL
NCT07108309
P2RecruitingTriple Negative Breast Cancer1242025-12
EDELWEISS
NCT06185335
P1/2Active, not recruitingHemophilia A502025-12
ELEFTA
NCT05445076
P2Active, not recruitingAxial Spondyloarthritis2502025-12
UNIVERSE
NCT06640530
P3Active, not recruitingAdvanced Melanoma; Melanoma (Skin)3922025-12
FLAMMINGO
NCT06668792
P2RecruitingRelapsed/Refractory Multiple Myeloma1002026-02
BCD-131 (pegdarbepoetin beta)
NCT07119372
P3Active, not recruitingAnemia; Chronic Kidney Disease2282026-05-12
PLANETA-KIDS
NCT06640517
P3Active, not recruitingPlaque Psoriasis1402026-06
NEO-MIMAJOR
NCT05751928
P3Active, not recruitingMelanoma Stage III; Melanoma (Skin)4112027-01
ULTRAMARINE
NCT07080034
P2RecruitingUlcerative Colitis (UC)1982027-01
MAGNOLIA
NCT06700096
P3RecruitingHemophilia B242027-04
COMANDOR
NCT07078994
P2RecruitingCrohn's Disease (CD)2042027-05
AMMADINA
NCT07742215
P3RecruitingMyeloma Multiple3902028-07
MUSCAT
NCT07321093
P3RecruitingRelapsing-remitting Multiple Sclerosis (RRMS)2922028-12